SBIR grant supports Protagonist's development of oral IL-23 receptor antagonists for IBD Sep. 28, 2015
Alector raises funds to advance immunomodulation approach for neurodegenerative diseases Sep. 21, 2015
ClearLight Diagnostics licenses Stanford IP for tissue processing and imaging technologies Sep. 17, 2015
RSS